NewsRx

Search our medical news database

Mergers & Acquisitions

VIASYS Healthcare acquires assets of BioBeat Medical, Ltd. for estimated $4.5 million

Published in Physician Law Weekly, November 29th, 2006

VIASYS Healthcare Inc. (VAS) announced that it has acquired the assets of BioBeat Medical, Ltd., for approximately $4.5 million. The acquired products, Sonara and Sonara/tek, incorporate advanced digital transcranial doppler (TCD) technology.

TCD is a noninvasive method of measuring blood flow velocities in the arteries of the brain using ultrasound Doppler technology. Sonara and Sonara/tek TCD systems have been rapidly adopted by neurovascular clinicians in Europe and Asia due to the systems' advanced performance and usability. The product line has such exclusive features as an intuitive user interface, superior signal acquisition, 250-gate high resolution M-Mode and...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Physician Law Weekly


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook